75 related articles for article (PubMed ID: 2263536)
1. Inhibition of intravascular platelet aggregation in the rat by adrenaline.
Botting JH; Oyekan AO; Hammady F
Pol J Pharmacol Pharm; 1990; 42(3):291-9. PubMed ID: 2263536
[TBL] [Abstract][Full Text] [Related]
2. Adrenaline inhibits adenosine diphosphate induced intravascular aggregation of rat platelets through stimulation of alpha 2 adrenoceptors.
Oyekan AO; Botting JH
Cardiovasc Res; 1991 May; 25(5):431-7. PubMed ID: 1677313
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic interaction between oestradiol and adrenaline on intravascular aggregation induced by adenosine diphosphate in the rat.
Oyekan AO; Botting JH
Arch Int Pharmacodyn Ther; 1990; 306():148-60. PubMed ID: 2076044
[TBL] [Abstract][Full Text] [Related]
4. The influence of adrenaline on gender difference in adenosine diphosphate-induced aggregation of platelets in the rat.
Oyekan AO; Botting JH
Thromb Haemost; 1988 Dec; 60(3):481-5. PubMed ID: 3238651
[TBL] [Abstract][Full Text] [Related]
5. Induction of platelet aggregation in vitro by microbubbles of nitrogen.
Thorsen T; Lie RT; Holmsen H
Undersea Biomed Res; 1989 Nov; 16(6):453-64. PubMed ID: 2603242
[TBL] [Abstract][Full Text] [Related]
6. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
Lanza F; Cazenave JP
Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
[TBL] [Abstract][Full Text] [Related]
7. Significance of platelet beta-adrenoceptors for platelet responses in vivo and in vitro.
Larsson PT; Wallén NH; Martinsson A; Egberg N; Hjemdahl P
Thromb Haemost; 1992 Dec; 68(6):687-93. PubMed ID: 1337630
[TBL] [Abstract][Full Text] [Related]
8. [Difference in inhibitory actions of products of the myeloperoxidase- catalyzed reaction on initial aggregation of activated platelets].
Rpshchupkin DI; Berzhitskaia VV; Murina MA
Biofizika; 1998; 43(2):323-8. PubMed ID: 9591107
[TBL] [Abstract][Full Text] [Related]
9. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.
Armstrong JM; Lefèvre-Borg F; Scatton B; Cavero I
J Pharmacol Exp Ther; 1982 Nov; 223(2):524-35. PubMed ID: 6127404
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of adrenaline and adenosine diphosphate induced platelet aggregation by Lansberg's hognose pit viper (Porthidium lansbergii hutmanni) venom.
Lopez-Johnston JC; de Bosch N; Scannone H; Rodríguez-Acosta A
Ann Hematol; 2007 Dec; 86(12):879-85. PubMed ID: 17891398
[TBL] [Abstract][Full Text] [Related]
11. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro.
Steen VM; Holmsen H; Aarbakke G
Thromb Haemost; 1993 Sep; 70(3):506-13. PubMed ID: 8259557
[TBL] [Abstract][Full Text] [Related]
12. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
Maayani S; Schwarz T; Craddock-Royal B; Tagliente TM
Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475
[TBL] [Abstract][Full Text] [Related]
13. Effects of imidazoline and non-imidazoline alpha-adrenergic agents on canine platelet aggregation.
Hikasa Y; Abe M; Satoh T; Hisashi Y; Ogasawara S; Matsuda H
Pharmacology; 1999 Apr; 58(4):171-82. PubMed ID: 10077736
[TBL] [Abstract][Full Text] [Related]
14. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods.
Milton JG; Frojmovic MM
J Lab Clin Med; 1984 Nov; 104(5):805-15. PubMed ID: 6387013
[TBL] [Abstract][Full Text] [Related]
15. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of pulmonary accumulation of 51chromium-labelled rat platelets following intravenous application of ADP and collagen.
Klee A; Seiffge D
Thromb Haemost; 1991 May; 65(5):588-95. PubMed ID: 1871721
[TBL] [Abstract][Full Text] [Related]
17. Potentiating effect of adrenaline on adenosine diphosphate-induced reduction in rabbit circulating platelet count: inhibition by dihydroergotoxine.
Holmes IB
Thromb Haemost; 1979 Aug; 42(2):641-8. PubMed ID: 41335
[TBL] [Abstract][Full Text] [Related]
18. Effect of clomipramine treatment on dog platelet alpha 2-adrenergic receptivity.
Villeneuve A; Berlan M; Paris H; Tran MA; Lafontan M; Montastruc JL; Montastruc P
J Pharmacol; 1986; 17(4):644-50. PubMed ID: 3031380
[TBL] [Abstract][Full Text] [Related]
19. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
[TBL] [Abstract][Full Text] [Related]
20. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
